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Should action take priority over further research on
public health?
We have evidence on which to act, and inaction costs lives, argue Simon Capewell and Paul
Cairney. But Aileen Clarke says our understanding of the human behaviour that leads to unhealthy
choices is still lacking
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Yes— Simon Capewell, Paul Cairney
Centuries of improvements in public health reflect actions not
excuses. There are important reasons to act now, rather than
wait for perfect evidence.
Firstly, we know what causes most avoidable disease and deaths:
poverty, poor diet, tobacco, and alcohol.1 And we know which
evidence based interventions work. Therefore, to wait for yet
more evidence is ethically unacceptable. Further delay will
perpetuate the current huge and unequal burden of harm. Policy
makers and clinicians need to act now, on a “balance of
probabilities,” not wait for a mythical evidence “magic bullet”
to remove all doubt.
Politics, evidence, and ambiguity
A focus on “insufficient evidence” often betrays a simplistic
view of policy making, that evidence is used merely to reduce
uncertainty. Politics is actually about using evidence to reduce
ambiguity. Evidence is important, but policy change requires a
powerful story and the ability to exploit windows of
opportunity.2 Effective political actors use evidence to draw
attention to urgent problems, encourage policy makers to
understand them primarily as epidemics, and generate demand
for evidence based public health solutions—for example, the
recent smoke-free legislation and levy on sugary drinks.
A delayed response to evidence can be damaging. For example,
a cumulative meta-analysis published in 1972 provided ample
evidence that thrombolysis reduced deaths from heart attack by
about 25%.3 However, repeated failure to consider this
substantial evidence, compounded by medical conservatism,
meant that thrombolysis was not widely used until 20 years
later. Many patients were thus denied effective treatment,4 likely
resulting in about 50 000 avoidable deaths over two decades in
the United States. Systematic reviews alone may not be
sufficient to change practice; evidence based guidelines need
to be developed and, crucially, implemented.
When scientists refer to “insufficient evidence” they may naively
help opponents of policy change, including vested interests.
Corporations producing harmful commodities such as tobacco,
alcohol, junk food, or sugary drinks routinely oppose regulation
or taxation because they reduce profits. These merchants of
doubt use MARSH “denialism” tactics5 6 to oppose public health.
MARSH stands for misinformation; attack of evidence,
scientists, and public health advocates; recruiting stooges;
substituting weak policies; and heaping money on politicians.
7
Without strong public health advocacy, these tactics can be
profoundly effective. For example, tobacco use contributes to
over six million premature deaths a year worldwide. However,
the global experience of tobacco policy suggests that industry
denial tactics can deflect effective regulation and thus allow
decades of delay between the identification of solid evidence
and a proportionate policy response.8
Learning from previous triumphs
We can learn useful lessons from previous public health
triumphs. All were predicated on action, not excuses to await
more evidence. Mackenzie recently summarised a century of
public health successes (including safe drinking water,
sanitation, immunisation, road safety and seat belts, tobacco
control, and pollution regulation).9 Each was built on a
foundation of scientific research. However, that evidence was
but the first step on the SUPPORT pathway of cumulative policy
change. SUPPORT stands for: scientific evidence emerges;
understanding spreads; professionals accept the model; public
and politicians become aware and then supportive; opposition
from vested interests is slowly overcome; regulation is
introduced; taxation is often used to reinforce regulations (as
in tobacco and alcohol control).7
Does responsibility for tackling known causes of preventable
disease lie mainly with individuals? No.10 We therefore suggest
that our over-riding ethical duty is to use evidence to maximise
current and future health for our patients, families, and
communities. Health professionals must therefore also ensure
that evidence based interventions are piloted and evaluated
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before widespread use, closely monitor their implementation
and outcomes, and modify as necessary.
In conclusion, we have a duty of care to our fellow humans to
accelerate policy reform through advocacy, not wait naively for
the evidence to “speak for itself.” The prize is a regulatory
framework that promotes a healthy environment, supports
healthy behaviour, and maintains clean drinking water, clean
air, and safe cars and buildings.10 These urgent rules of evidence
in action are thus very different to the “wait and see” rules of
endless evidence production.
The huge current burden of avoidable disease is a scandal.
“Insufficient evidence” is an excuse for dither and deaths. We
already have enough evidence to support public health; what
we need now is more action from policy makers, managers, and
clinicians.
No—Aileen Clarke
Proponents for action are clear about the changes needed to
improve public health: we need to eat less, consume less sugar,
and take more exercise. The effects of obesity, poor diet, lack
of physical activity, and overconsumption of alcohol and fizzy
sugary drinks are plain, they say. The research needed to
improve public health is done and dusted, and all we need to
do is get on with things. Yet a central question remains. If the
causes of ill health are clear and all that is required is for us to
take action, why hasn’t this happened?
Research shapes our understanding of health and wellbeing.
Research informs policy, and policy interprets and informs
research. Research is key to understanding how individuals and
organisations, governments, and industries behave. Research is
vital to interpret the likely effects of changes in our attitudes,
cultures, and societies, as well as in our politics, economics,
and ultimately in our health and wellbeing.
Understanding healthier choices
Clearly, there is still research to do. How do we continue to
improve the health generating environment so that people can
make the best choices to become healthier? And more research
is needed to understand how a person can make long term
choices to sustain and improve health, through his or her life.
Public health research has tended to focus on the epidemiology
and causes of diseases such as heart disease, cancer, and stroke.
But insufficient attention has been paid to interventions that
target the underlying causes of reduced wellbeing and disability.
We know so much about the distribution and causes of obesity
and diabetes, for example, but not enough about what to do
about them.
We know that a waist circumference greater than 90 cm for men
and 83 cm for women should prompt action, because of altered
blood glucose metabolism and subsequent diabetes.11 However,
we do not yet have a reliable mechanism (apart from expensive
surgery) to help people maintain and limit their weight that
really works on a long term basis.
Meanwhile, 38% of US adults have prediabetes and 33% of
older US adults have diabetes.12 And just under 10% of UK
children at age 4-5 years arrive at school already obese.13 Why
do the couch, the television, and the car sometimes appeal more
than the park, the gym, and the bicycle? For our future health
and wellbeing, we desperately need research to help us
understand our behaviour better.14 We know precisely how much
salt leads to what increase in blood pressure,15 with what
cardiovascular risk,16 17 but we still don’t really know why our
taste for salt, sugar, and fat is so persistent.
Last year Public Health England reported that despite
widespread publicity on the benefits of exercise, six million
adults in England do not take even a single 10 minute walk a
month.18 More worryingly, the increase in life expectancy in
the UK has slowed, and women are now spending more years
in poor health.19 We need a new approach to research to improve
public health, a personal and social approach that does not just
log declines in population indicators but which considers us as
individuals who make choices within our social contexts.
Socially robust knowledge
Nowotny suggests that research needs to acknowledge “social,
economic, cultural and political factors.”20 Such “socially robust
knowledge” gets under our skin, helping us to understand how
we tick. Scientific knowledge needs to be produced that can
speak to us as ordinary people. Kelly and Russo, for example,
describe refocusing research about preventing alcohol misuse
from the aetiological to the practical.21 Understanding “social
practices” and “settings and contexts” are key, they argue.
However, behaviour change sciences are still young and
relatively underfunded. In its report on behaviour change, the
House of Lords science and technology select committee
concluded that much is understood about human behaviour but
there is “relatively little evidence on how to change the
behaviour of populations.”22
Clearly we need more research in public health. Research is
needed now to interpret current knowledge and to develop
socially robust and practical ways to change and sustain our
individual behaviour, to improve our individual health, and thus
to improve the public health of our patients, families, and
communities.
Provenance and peer review: Commissioned; not externally peer
reviewed.
Competing interests: All authors have read and understood BMJ policy
on declaration of interests and have no relevant interests to declare.
AC is partly supported by the NIHR CLAHRC West Midlands initiative.
The views expressed here are those of the authors and not necessarily
those of the NHS, the National Institute for Health Research, or the
Department of Health.
Provenance and peer review: Commissioned; not externally peer
reviewed.
1 Newton JN, Briggs ADM, Murray CJL. Changes in health in England, with analysis by
English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global
Burden of Disease Study 2013. Lancet 2015;386:2257-74.
doi:10.1016/S0140-6736(15)00195-626382241
2 Cairney P, Oliver K, Wellstead A. To bridge the divide between evidence and policy:
reduce ambiguity as much as uncertainty. Public Adm Rev
2016;76:399-402doi:10.1111/puar.12555.
3 Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative
meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
doi:10.1056/NEJM1992072332704061614465
4 Ford ES, Ajani UA, Croft JB. Explaining the decrease in US deaths from coronary disease,
1980-2000. N Engl J Med 2007;356:2388-98. doi:10.1056/NEJMsa05393517554120
5 Oreskes N, Conway EM. Merchants of doubt: how a handful of scientists obscured the
truth on issues from tobacco smoke to global warming. OCLC, 2010.
6 Chan M. 2013. WHO director-general opening address at the 8th global conference on
health promotion. Helsinki, Finland, 10 June 2013. http://www.who.int/dg/speeches/2013/
health_promotion_20130610/en/
7 Capewell S, Lloyd Williams F. The role of the food industry in health: lessons from tobacco?
Br Med Bull 2018 (forthcoming).
8 Cairney P, Studlar D, Mamudu H. Global tobacco control. Palgrave,
2012doi:10.1057/9780230361249.
9 Mackenzie G. A public health century #APHCentury. https://storify.com/gmacscotland/a-
public-health-century-aphcentury-full-version
10 Capewell S, Lilford R. Are nanny states healthier states?BMJ 2016;355:i6341.
doi:10.1136/bmj.i634127927622
11 Friedl KE. Waist circumference threshold values for type 2 diabetes risk. J Diabetes Sci
Technol 2009;3:761-9. doi:10.1177/19322968090030042420144326
12 Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among
adults in the United States, 1988-2012. JAMA 2015;314:1021-9.
doi:10.1001/jama.2015.1002926348752
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2018;360:k292 doi: 10.1136/bmj.k292 (Published 1 February 2018) Page 2 of 3
HEAD TO HEAD
13 National Statistics. National child measurement programme England, 2016/17 school
year. ONS, 2017. https://digital.nhs.uk/catalogue/PUB30113
14 Marteau T, Dieppe P, Foy R, Kinmonth AL, Schneiderman N. Behavioural medicine:
changing our behaviour. BMJ 2006;332:437-8. doi:10.1136/bmj.332.7539.43716497737
15 He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure:
Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325.
doi:10.1136/bmj.f1325.23558162
16 Lewington S, Clarke R, Qizilbash N, Peto R, Collins RProspective Studies Collaboration.
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of
individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
doi:10.1016/S0140-6736(02)11911-812493255
17 Cook NR, Cutler JA, Obarzanek E. Long term effects of dietary sodium reduction on
cardiovascular disease outcomes: observational follow-up of the trials of hypertension
prevention (TOHP). BMJ 2007;334:885-8. doi:10.1136/bmj.39147.604896.5517449506
18 Public Health England. 10 minutes brisk walking each day in mid-life for health benefits
and towards achieving physical activity recommendations. Evidence summary. PHE,
2017. Gateway No: 2017294.
19 Public Health England, Health profile for England. Chapter 1: life expectancy and healthy
life expectancy. PHE, 2017.Gateway No 2017051.
20 Nowotny H. Dilemma of expertise: democratising expertise and socially robust knowledge.
Sci Public Policy 2003;30:151-6doi:10.3152/147154303781780461.
21 Kelly MP, Russo F. Causal narratives in public health: the difference between mechanisms
of aetiology and mechanisms of prevention in non-communicable diseases. Sociol Health
Illn 2018;40:82-99. doi:10.1111/1467-9566.12621.29023919
22 House of Lords Science and Technology Select Committee. Behaviour change. 2011.
https://www.publications.parliament.uk/pa/ld201012/ldselect/ldsctech/179/179.pdf
Published by the BMJ Publishing Group Limited. For permission to use (where not already
granted under a licence) please go to http://group.bmj.com/group/rights-licensing/
permissions
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2018;360:k292 doi: 10.1136/bmj.k292 (Published 1 February 2018) Page 3 of 3
HEAD TO HEAD
